Blackstone Inc’s Transmedics TMDX Stock Holding History

Blackstone Inc’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$290K	–	93
2019 Q2	$290K	Buy	+10,000	New	+$273K	﹤0.01%	86

Other funds holding TMDX

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blackstone Inc's TMDX Position: Q3 2019 in Review

Blackstone Inc sold out of Transmedics (TMDX) in Q3 2019, closing a stake of 10,000 shares — an estimated $290K sold.

Blackstone Inc first reported a position in TMDX in Q2 2019 and held it in 1 quarter. The position peaked at $290K in Q2 2019. 50 funds tracked by Wall St. Rank hold TMDX as of Q3 2019.

Blackstone Inc reported no remaining Transmedics position as of Q3 2019 after selling out during the quarter.
Blackstone Inc sold 10,000 Transmedics shares in Q3 2019, an estimated $290K.
Blackstone Inc first reported a position in Transmedics in Q2 2019 and held it in 1 quarter.
Blackstone Inc's Transmedics position peaked at $290K in Q2 2019.
50 funds tracked by Wall St. Rank held Transmedics as of Q3 2019.

Based on Blackstone Inc's 13F filing for Q3 2019, filed 14 Nov 2019.